National Institute of Pharmaceutical Education and Research Placements 2026

Mohali, Punjab Approved By: AICTEPCI Government Estd: 1998 Gender: Coed
Angel Youth Education TeamContent writer
Updated At : Nov 18, 2026 11:18 AM

NIPER Mohali career outcomes reflect the institute’s research orientation. The 2025 placement cycle recorded a highest CTC of INR 15 LPA (Pfizer) and an average CTC of INR 6 to 8 LPA for PG graduates. Of 268 eligible students, 213 were placed, reflecting a placement rate of 79%. Over 40 companies participated, with pharma contributing 80% and biotech 15% of the total offers.

Programme 2025 Highest CTC 2025 Average CTC Key Sectors
M.Pharm (all streams) INR 15 LPA (Pfizer) INR 6 to 8 LPA R&D, Regulatory
MS (Pharm) INR 12 to 15 LPA INR 6 to 7 LPA Biotech, Pharmacoinformatics
MBA (Pharma Management) INR 10 LPA (Novartis) INR 7 to 9 LPA Commercial, Regulatory

Top recruiters from the 2025 cycle included Pfizer, Mylan, Zydus Cadila, Syngene, Himalaya, and Novartis. R&D roles accounted for 75% of all placements, with regulatory affairs taking a further 20%. A significant share of NIPER graduates also pursue Ph.D or post-doctoral research in India and abroad, particularly in the United States, Europe, and Canada.

Cognizant
Coromandel International Limited
Evalueserve
Ranbaxy Laboratories
ZS Associates
Syngenta Biosciences
BioCon Ltd.
Piramal
Perkin Elmer
Lupin
Cadila Pharmaceuticals Ltd
Jubliant
Torrent Pharmaceuticals
Novartis
Sun Pharmaceuticals
Alembic Pharmaceuticals
Matrix Labs
Zydus Cadila Ltd.
WNS Global
Confused about admission in NIPER Mohali?Talk to our expert counsellors – it's free.
Chat with us

Get In Touch With Us

By submitting this form you agree that Angel Youth Education may use the details you provide to respond to you, as described in our privacy notice.